Search clinical trials for: Mycophenolic Acid

Total 23784 results

University of Cincinnati
Novartis

Completed

Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal

End Stage Renal Disease (ESRD)

United States
University of North Carolina, Chapel Hill
Novartis Pharmaceuticals

Completed

Myfortic Conversion Trial in OLT Recipients With GI Intolerance

GI Disturbance

United States
EMD Serono
Merck KGaA, Darmstadt, Germany

Completed

First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available

United States
University of Cincinnati
Novartis Pharmaceuticals

Completed

Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients

Kidney Transplant Recipients

United States
Rodolfo Alejandro

Recruiting

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

Type 1 Diabetes Mellitus

United States
University of Utah

Completed

Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State

Kidney Transplantation

United States
The Third Affiliated Hospital of Southern Medical...

Unknown

The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear

Lupus Nephritis

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
Hoffmann-La Roche; Sanquin Research & Blood Bank Divisions

Unknown

Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

HIV Infection

Netherlands
Qualitix Clinical Research Co., Ltd.

Unknown

Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis (Myfortic)

Myasthenia Gravis
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients

HIV Infection | Atherosclerosis

Netherlands
R. Mark Ghobrial, MD
Novartis

Completed

Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation

End Stage Liver Disease

United States
Region Skane

Completed

Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis (MMFSSC)

Systemic Sclerosis | Gastrointestinal Complication

Sweden
Hospital Universitario Fundación Alcorcón
Hospital General Universitario Gregorio Marañon; Hospital Universitario Ramon... and other collaborators

Withdrawn

Clinical Trial Treatment in Lupus Nephritis (Csa-LES)

Lupus Nephritis

Spain
London Health Sciences Centre

Completed

Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

Hepatitis C

Canada
University Medical Center Groningen
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Leiden University...

Completed

Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen (Allegro)

Renal Insufficiency | Kidney Transplantation

Netherlands
Milton S. Hershey Medical Center
Novartis Pharmaceuticals

Completed

Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.

Renal Failure | Immunosuppression

United States
Assiut University

Unknown

Predictors of Rejection in Pediatric Kidney Transplantation

Rejection Acute Renal
University of Wisconsin, Madison
Novartis Pharmaceuticals

Terminated

Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation

Liver Transplant

United States
Seoul St. Mary's Hospital
Novartis

Unknown

Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients (PROTECT)

Kidney; Complications, Allograft

Korea, Republic of
University of Pittsburgh
Novartis Pharmaceuticals

Completed

Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients

Immunosuppression

United States
The University of Texas Health Science Center,...
Novartis

Withdrawn

Enteric Coated Myfortic for Liver Transplant Recipients

Liver Transplantation

United States
Georgetown University
Novartis

Withdrawn

Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation

Kidney Transplantation | Reperfusion Injury | Renal Transplantation
Montefiore Medical Center

Terminated

Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity

Chronic Allograft Injury | Calcineurin Inhibitor Toxicity

United States
University of California, San Francisco

Completed

Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients

BK Virus Infection

United States
University Hospital, Bordeaux
Novartis

Completed

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A (EVERCMV)

Transplantation Infection | Cytomegalovirus Infection

France
Centre Hospitalier Universitaire de Saint Etienne

Completed

Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus Post Kidney Transplant: The Myfortic Study

Kidney Transplantation

France
M.D. Anderson Cancer Center
Ovarian Spore

Withdrawn

High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection

Uterine Cancer
Eisai Co., Ltd.

Completed

A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease

Non-erosive Gastroesophageal Reflux Disease

Japan
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

No longer available

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

Diabetes Mellitus, Type 1

United States
Novartis Pharmaceuticals

Completed

24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients (EVITA)

Renal Transplant

Spain
Astellas Pharma China, Inc.

Completed

Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients

Kidney Transplant

China
Hospital do Rim e Hipertensão

Completed

Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation (SEM)

Kidney Transplant Infection

Brazil
Surface Pharmaceuticals, Inc.

Completed

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Novartis

Completed

Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

Kidney Transplantation | Graft Rejection

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

Bone Marrow Failure Syndromes | Severe Aplastic Anemia

United States
Mayo Clinic
Roche Pharma AG

Terminated

A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

Kidney Transplantation | Delayed Graft Function

United States
Genovate Biotechnology Co., Ltd.,
Novartis

Unknown

Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study

Uveitis

Taiwan
Medical University of South Carolina
Hoffmann-La Roche

Terminated

Mycophenolate for Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States
University of Florida
Novartis

Completed

Desensitization of Renal Transplant Candidates

End Stage Renal Disease | Kidney Transplantation

United States
McGill University Health Centre/Research Institute...
Novartis

Unknown

Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms

Heart Transplant Patients

Canada
Seoul National University Hospital
National Institute of Food and Drug Safety Evaluation (Republic of Korea)

Recruiting

Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation

Korea, Republic of
Chulalongkorn University
Berlin Pharmaceutical Industry

Terminated

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

Lupus Nephritis

Thailand
Columbia University

Completed

Study of CellCept for Advanced Pancreatic Cancer

Pancreatic Cancer

United States
King Faisal Specialist Hospital & Research Center

Unknown

Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Saudi Arabia
Children's Hospital Medical Center, Cincinnati

Withdrawn

Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis (PRUNE)

Lupus Nephritis
Novartis

Completed

Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant

Kidney Transplantation

Brazil
Emory University

Terminated

Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept

Cardiac Transplantation

United States
University Hospital, Limoges
Hoffmann-La Roche

Unknown

Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients

Kidney Transplant Recipients

France
Clinical Hospital Merkur
University Hospital Rijeka; University Medical Centre Ljubljana

Completed

Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

Kidney Transplantation | Kidney Failure

Croatia
Novartis Pharmaceuticals

Completed

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Kidney Transplantation

France, Germany, United Kingdom, Spain, Switzerland, United States, Canada, Italy

3

Subscribe